分子腫瘍学講座 ｜ 信州大学(Molecular Oncology | Shinshu Univ.) > Home(index.-E.html)

Professor Shun'ichiro Taniguchi Awarded by Kobayashi Foundation for Cancer Research

Our Laboratory becomes affiliated with a newly established research group in Shinshu University,IBSS(Institute for Biomedical Science, Shinshu University).

Annual Meeting of the Japanese Association for Metastasis Research ended successfully.

Annual Meeting of the Japanese Association for Metastasis Research

will be held in Matsumoto July 11Thu. - 12Fri. in 2013. Please join us.

The previous Institute on Aging and Adaptation(April 2003~ March 2012) has been further evolved into the Institute of Pathogenesis and Disease Prevention, Shinshu University Graduate School of Medicine, from April 2012 as a Doctoral course. The mission of the new institute is to cover comprehensive education and research on preventive medicine, which is one of the main research projects of Shinshu University.

14th International Biennial Congress of the Metastasis Research Society

will be held in Brisbane, Australia, in 2012. S. Taniguchi has been nominated as a con-convener along with Prof. Erik Thompson from the University of Melbourne.

Our campus

can now be seen on Google Street View.

A short essay by S. Taniguchi has been published in a Science Journal

(“Kagaku”, published by Iwanami Shoten, March 2011 issue).

Anaeropharma has successfully completed closing of 700 million yen financing for its clinical trials.

The investor – Innovation Network Corporation of Japan (INCJ)

- plans to contribute indefinitely to Anaeropharma’s future financing.

Anaeropharma Science, Inc. andEisai Co., Ltd., have reached an agreement concerning

APS001, a novel anticancer agentcurrently under development at Anaeropharma Science that utilizes the characteristic features of Bifidobacterium longum. The two companies have also agreed to begin collaborating on the discovery of novel anticancer agents that utilize Bifidobacterium as a drug delivery system.